1. Home
  2. GSIT vs YARW Comparison

GSIT vs YARW Comparison

Compare GSIT & YARW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GSI Technology

GSIT

GSI Technology

N/A

Current Price

$3.07

Market Cap

184.9M

Sector

Technology

ML Signal

N/A

Logo Yarrow Bioscience Inc. Common Stock

YARW

Yarrow Bioscience Inc. Common Stock

N/A

Current Price

$18.88

Market Cap

154.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GSIT
YARW
Founded
1995
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
184.9M
154.5M
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
GSIT
YARW
Price
$3.07
$18.88
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $57.33
AVG Volume (30 Days)
★ 467.8K
175.0K
Earning Date
11-05-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.33
EPS
★ N/A
N/A
Revenue
★ $25,122,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$16.95
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 22.44
N/A
52 Week Low
$2.93
$12.39
52 Week High
$13.00
$44.28

Technical Indicators

Market Signals
Indicator
GSIT
YARW
Relative Strength Index (RSI) 30.56 48.63
Support Level N/A $18.05
Resistance Level $5.82 $20.57
Average True Range (ATR) 0.29 2.44
MACD -0.02 0.46
Stochastic Oscillator 9.69 77.19

Price Performance

Historical Comparison
GSIT
YARW

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia and customers segregated as-Contract manufacturers, Distribution and OEMs. In addition, it serves the ongoing needs of the military, aerospace and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and USA.

About YARW Yarrow Bioscience Inc. Common Stock

Yarrow Bioscience Inc is a clinical-stage biopharmaceutical company focused on developing biotherapeutics for autoimmune thyroid diseases. Its flagship product candidate, YB-101 (also known as GenSci098), is a humanized, monoclonal antibody targeting the thyroid-stimulating hormone receptor, which Yarrow plans to develop for the treatment of Graves' disease (GD) and potentially thyroid eye disease (TED). The company has one reportable segment relating to the research and development of its research programs, GD and TED.

Share on Social Networks: